Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia

Clinical trial NCT07615075 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07615075
Sponsor: University of Maryland, Baltimore
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizo Affective Disorder Healthy

Start date: 2026-09-01
Primary completion: 2029-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.